Japanese Residential REITs Stock News

Kumiai Chemical Industry (TSE:4996) has just posted Q2 2026 numbers with revenue of ¥56,212 million and basic EPS of ¥39.89, setting a clear marker for the latest quarter. The company’s quarterly revenue moved from ¥52,796 million in Q2 2025 to ¥56,212 million in Q2 2026, while basic EPS over the same quarters shifted from ¥18.86 to ¥39.89, against a trailing twelve month EPS of ¥56.92 on revenue of ¥177,204 million. For investors, the key point is how these earnings compare with a thinner...

Last week's earnings announcement from Daisan Co., Ltd. ( TSE:4750 ) was disappointing to investors, with a sluggish...

Nissan’s Africa, Middle East, India, Europe and Oceania division has already completed a full rollout of its new parts pricing solution across about 40 primary and more than 140 export markets, replacing its legacy system and giving teams a unified, scalable platform to manage aftermarket pricing. This move highlights how Nissan is treating its global aftermarket business as a core growth lever, seeking more consistent and precise pricing to underpin parts sales across a complex,...

In June 2026, MonotaRO Co., Ltd. reported that its preliminary non-consolidated sales for May reached ¥28,840 million, up from ¥24,964 million a year earlier. The company also added 115,500 new customer accounts and cited royalty income from overseas operations as a contributor to its May sales performance. Next, we will consider how this combination of higher monthly sales and rapid customer acquisition shapes MonotaRO’s broader investment narrative. Invest in the nuclear renaissance...

Earlier in June 2026, Sekisui House, Ltd. reported first-quarter sales of ¥908,878 million and net income of ¥58,479 million, alongside filing a ¥150 billion bond shelf registration. The sharp rise in quarterly net income and earnings per share, compared with the prior year, highlights a period of markedly stronger profitability. We’ll now examine how this stronger first-quarter profitability shapes Sekisui House’s investment narrative in light of its recent share price move. Invest in the...

FDA clearance puts HOYA (TSE:7741) endoscopy devices in focus HOYA (TSE:7741) has secured US FDA clearance for new PENTAX Medical i20c Video Endoscope models, giving the company a green light to broaden its gastrointestinal endoscopy offering in US hospitals. See our latest analysis for HOYA. The recent FDA clearance arrives after a mixed patch for the stock, with the share price up 9.54% year to date but seeing a 1 month share price return that declined 4.52%, while the 1 year total...

In June 2026, Furukawa Electric Co., Ltd. issued consolidated earnings guidance for the fiscal year ending March 31, 2027, forecasting net sales of ¥1,460.00 billion, operating profit of ¥95.00 billion, and profit attributable to owners of parent of ¥82.00 billion. This fresh forecast gives investors a clearer view of management’s expectations for profitability, highlighting how Furukawa Electric sees its earnings mix developing over the coming year. Next, we’ll examine how Furukawa...

In June 2026, Teradyne announced an integrated test cell solution for AI and data center chips that combines its UltraFLEXplus platform with Tokyo Electron’s Prexa SDP prober to enable high-quality known good device screening across advanced 2.5D and 3D packaging flows. This collaboration highlights Tokyo Electron’s role in addressing reliability and yield challenges in chiplet-based architectures, where a single faulty die can compromise an entire high-value package. We’ll now examine how...

Event context and recent price action Sharp (TSE:6753) has drawn investor attention after recent trading saw the stock down about 7% over the past week, while still up roughly 7% over the past month. See our latest analysis for Sharp. While the recent 7 day share price return shows a decline and short term momentum has cooled, the 1 year total shareholder return is also down, pointing to longer running pressure on the stock. If this kind of reset has you looking beyond consumer electronics,...

Why Meiko Electronics (TSE:6787) is back in focus Recent media coverage around Meiko Electronics (TSE:6787), highlighting its high insider ownership and strong revenue growth profile, has pulled the stock back into the spotlight for investors watching Asian electronics companies. Meiko Electronics is being discussed alongside other Asian growth companies after reports pointed to insider ownership of 19.2% and annual revenue growth of 27.9%. This has prompted closer attention to its...

Earlier this month, Credit Saison Co., Ltd. issued earnings guidance for the fiscal year ending March 31, 2027, projecting consolidated net revenue of ¥507,500 million and profit attributable to owners of parent of ¥75,500 million, alongside updated non-consolidated forecasts. The company also proposed lifting its annual dividend to ¥130.00 per share for the year ended March 31, 2026 and guiding to a further increase to ¥160.00 for the 2027 fiscal year, highlighting a stronger emphasis on...

Trend Micro stock moves: what recent performance suggests Trend Micro (TSE:4704) has been trading without a clear single catalyst, so recent moves offer a snapshot of how the cybersecurity stock is currently priced and how its returns stack up over different periods. See our latest analysis for Trend Micro. Recent trading has been choppy, with the share price down 3.83% over the last day and 11.65% over the past week, yet still showing a 30 day share price return of 7.84% and a 1 year total...

Air Water (TSE:4088) cut its year end dividend to ¥37.50 per share for the fiscal year ended March 31, 2026, from ¥43.00, following a review tied to previously disclosed inappropriate accounting. See our latest analysis for Air Water. At a share price of ¥2,441.0, Air Water’s 30 day share price return of 12.02% and 90 day share price return of 16.10% point to solid recent momentum. The 1 year total shareholder return of 21.01% and 5 year total shareholder return of 68.27% show investors have...

Recent share performance and context SMC (TSE:6273) has drawn attention after recent price swings, with the stock up 5.8% on the day, roughly flat over the past week, but down 17.6% over the past month. See our latest analysis for SMC. The recent 1 month share price return, down 17.6%, contrasts with a 1 year total shareholder return of 27.1%. This suggests that momentum has cooled after a stronger run for longer term holders. If you are comparing SMC with other industrial automation and...

In recent days, front-end semiconductor equipment makers such as SCREEN Holdings have held up well despite a sharp Nikkei Average pullback, as investors focused on AI-related chip demand and strong ordering trends from major foundries like TSMC. Additional optimism has come from reports that Rapidus signed semiconductor R&D memoranda of understanding with the UK and Italy, supporting sentiment toward related equipment suppliers. Investor attention has increasingly centered on SCREEN...

Ajinomoto Co., Inc. recently reported record fiscal year-end earnings while keeping prices for its Ajinomoto Build-up Film (ABF) unchanged despite strong AI-related demand and announcing capacity expansion targeting production in 2032. The company also introduced a three-tier pricing structure in Japan to support margins, highlighting differing pricing power between its frozen foods and seasonings businesses and underlining how its electronic materials and core food segments are being...

Toyota Motor (TSE:7203) has moved into the spotlight after challenging proposed EU rules on local sourcing and highlighting new airbag technology for Lexus, a mix of policy risk and product focus investors may reassess. See our latest analysis for Toyota Motor. The share price has pulled back recently, with a 30 day share price return of 7.73% and a 90 day share price return of 17.64%. However, the 1 year total shareholder return of 11.94% and 5 year total shareholder return of 62.57% suggest...

May sales beat highlights Aeon’s value and mall-driven model Aeon (TSE:8267) caught investor attention after May 2026 sales were described as strong, with seasonal and discretionary categories supported by stable demand for essentials across its multi format retail network. The sales update also highlighted rising traffic at Aeon Mall specialty stores, where experience oriented tenants and new leisure facilities are drawing shoppers and helping lift same store sales within the broader group...

MITSUI-SOKO HOLDINGS (TSE:9302) is back in focus after reporting FY2026 revenue and profit growth, with better margins and a stronger balance sheet. The results were supported by steady dividends and a positive management outlook. See our latest analysis for MITSUI-SOKO HOLDINGS. At a share price of ¥3,878, MITSUI-SOKO HOLDINGS has had a fairly steady year overall, with modest short term share price gains and a very strong multi year total shareholder return that suggests earlier momentum has...

AI transcript partnership puts Japan Exchange Group in focus RavenPack’s tie-up with JPX Market Innovation & Research to pipe SCRIPTS Asia earnings transcripts and disclosures into AI workflows is drawing fresh attention to Japan Exchange Group (TSE:8697) as a core infrastructure stock in Japanese equities. See our latest analysis for Japan Exchange Group. The stock’s recent news sits alongside strong price momentum, with a 30-day share price return of 17.53% and a 1-year total shareholder...

In recent days, SMBC Nikko upgraded Pigeon Corporation’s rating from Neutral to Outperform, indicating a more favourable stance on the company’s prospects. This shift in brokerage opinion highlights how changes in analyst sentiment can influence how investors weigh Pigeon’s longer-term business narrative. We’ll now examine how SMBC Nikko’s more favourable rating for Pigeon shapes the company’s investment narrative and key appeal for investors. Invest in the nuclear renaissance through our...

Astellas Pharma has overhauled its drug development model by bringing clinical operations in-house and using AI tools, while advancing its KRAS-targeting candidate setidegrasib into a phase 3 pancreatic cancer trial to compete in a crowded oncology field. This shift towards AI-enabled, internal clinical execution underscores how Astellas is trying to sharpen R&D efficiency and strengthen its position across oncology and other high‑value areas like gene therapy, blindness, and targeted...

KG Intelligence CO., LTD. ( TSE:2408 ) is about to trade ex-dividend in the next three days. The ex-dividend date...

Metaplanet stock in focus Metaplanet (TSE:3350) is back on investors’ radars after a recent move in its share price, with the stock closing at ¥232 and short term returns showing sharp swings over the past year. See our latest analysis for Metaplanet. The recent 1 day share price return of 3.57% comes after a series of weaker periods, with the 30 day share price return down 24.92% and the year to date share price return down 50.43%, while the 3 year total shareholder return remains very...